Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1997 Jan;4(1):64–69. doi: 10.1128/cdli.4.1.64-69.1997

Relation of impaired lymphocyte proliferative function to other major human immunodeficiency virus type 1-induced immunological changes.

H Z Bass 1, J L Fahey 1, P Nishanian 1, R Detels 1, W Cumberland 1, M Kemeny 1, S Plaeger 1
PMCID: PMC170477  PMID: 9008283

Abstract

Human immunodeficiency virus (HIV) type 1 (HIV-1) induces impairment of immune function reflected in reduced lymphocyte proliferative responses. Many other immune changes are induced by HIV-1, but their relationship to lymphocyte functional defects is not known. The present study was designed to correlate functional defects with other HIV disease parameters. Cryopreserved samples from 118 HIV-1-positive subjects and 40 seronegative individuals were examined. The main findings were that impaired proliferative responses to mitogens correlated with (i) decreased cell surface expression of the interleukin-2 receptor (CD25), (ii) increased expression of HLA-DR antigens on CD4 cells, (iii) reduced CD4 and increased CD8 cell numbers, and (iv) increased levels of serum immune complex dissociated p24 antigen. However, impaired function was not associated with increased serum neopterin, beta2-microglobulin, or soluble interleukin-2 receptor or with CD38 antigen expression on lymphocytes. In summary, proliferative functional impairment correlated with some, but not all, immunological changes associated with HIV-1 infection. Most of the phenotypic markers that correlated with altered function are cell surface molecules with significant roles in lymphocyte proliferation and were associated primarily with CD4 cells, compatible with the view that dysregulation of CD4 cells is responsible for impaired function.

Full Text

The Full Text of this article is available as a PDF (201.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bass H. Z., Hardy W. D., Mitsuyasu R. T., Taylor J. M., Wang Y. X., Fischl M. A., Spector S. A., Richman D. D., Fahey J. L. The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals. J Acquir Immune Defic Syndr. 1992;5(3):215–221. [PubMed] [Google Scholar]
  2. Bass H. Z., Hardy W. D., Mitsuyasu R. T., Wang Y. X., Cumberland W., Fahey J. L. Eleven lymphoid phenotypic markers in HIV infection: selective changes induced by zidovudine treatment. J Acquir Immune Defic Syndr. 1992;5(9):890–897. [PubMed] [Google Scholar]
  3. Bass H. Z., Nishanian P., Hardy W. D., Mitsuyasu R. T., Esmail E., Cumberland W., Fahey J. L. Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens. Clin Immunol Immunopathol. 1992 Jul;64(1):63–70. doi: 10.1016/0090-1229(92)90060-2. [DOI] [PubMed] [Google Scholar]
  4. Clerici M., Stocks N. I., Zajac R. A., Boswell R. N., Lucey D. R., Via C. S., Shearer G. M. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest. 1989 Dec;84(6):1892–1899. doi: 10.1172/JCI114376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Detels R., Visscher B. R., Fahey J. L., Sever J. L., Gravell M., Madden D. L., Schwartz K., Dudley J. P., English P. A., Powers H. Predictors of clinical AIDS in young homosexual men in a high-risk area. Int J Epidemiol. 1987 Jun;16(2):271–276. doi: 10.1093/ije/16.2.271. [DOI] [PubMed] [Google Scholar]
  6. Fahey J. L., Taylor J. M., Detels R., Hofmann B., Melmed R., Nishanian P., Giorgi J. V. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med. 1990 Jan 18;322(3):166–172. doi: 10.1056/NEJM199001183220305. [DOI] [PubMed] [Google Scholar]
  7. Fan J., Bass H. Z., Fahey J. L. Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection. J Immunol. 1993 Nov 1;151(9):5031–5040. [PubMed] [Google Scholar]
  8. Gelmann E. P., Preble O. T., Steis R., Lane H. C., Rook A. H., Wesley M., Jacob J., Fauci A., Masur H., Longo D. Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters. Am J Med. 1985 May;78(5):737–741. doi: 10.1016/0002-9343(85)90276-1. [DOI] [PubMed] [Google Scholar]
  9. Giorgi J. V., Detels R. T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study. Clin Immunol Immunopathol. 1989 Jul;52(1):10–18. doi: 10.1016/0090-1229(89)90188-8. [DOI] [PubMed] [Google Scholar]
  10. Giorgi J. V., Nishanian P. G., Schmid I., Hultin L. E., Cheng H. L., Detels R. Selective alterations in immunoregulatory lymphocyte subsets in early HIV (human T-lymphotropic virus type III/lymphadenopathy-associated virus) infection. J Clin Immunol. 1987 Mar;7(2):140–150. doi: 10.1007/BF00916008. [DOI] [PubMed] [Google Scholar]
  11. Hofmann B., Bass H., Nishanian P., Faisal M., Figlin R. A., Sarna G. P., Fahey J. L. Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha. Clin Exp Immunol. 1992 Jun;88(3):548–554. doi: 10.1111/j.1365-2249.1992.tb06485.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hofmann B., Bygbjerg I., Dickmeiss E., Faber V., Frederiksen B., Gaub J., Gerstoft J., Jakobsen B. K., Jakobsen K. D., Lindhardt B. O. Prognostic value of immunologic abnormalities and HIV antigenemia in asymptomatic HIV-infected individuals: proposal of immunologic staging. Scand J Infect Dis. 1989;21(6):633–643. doi: 10.3109/00365548909021691. [DOI] [PubMed] [Google Scholar]
  13. Hofmann B., Jakobsen K. D., Odum N., Dickmeiss E., Platz P., Ryder L. P., Pedersen C., Mathiesen L., Bygbjerg I. B., Faber V. HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway. J Immunol. 1989 Mar 15;142(6):1874–1880. [PubMed] [Google Scholar]
  14. Hofmann B., Nishanian P., Fahey J. L., Esmail I., Jackson A. L., Detels R., Cumberland W. Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: distinctive parameters of HIV-induced change. Clin Immunol Immunopathol. 1991 Nov;61(2 Pt 1):212–224. doi: 10.1016/s0090-1229(05)80025-x. [DOI] [PubMed] [Google Scholar]
  15. Hofmann B., Wang Y. X., Cumberland W. G., Detels R., Bozorgmehri M., Fahey J. L. Serum beta 2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis. AIDS. 1990 Mar;4(3):207–214. [PubMed] [Google Scholar]
  16. Kaslow R. A., Ostrow D. G., Detels R., Phair J. P., Polk B. F., Rinaldo C. R., Jr The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol. 1987 Aug;126(2):310–318. doi: 10.1093/aje/126.2.310. [DOI] [PubMed] [Google Scholar]
  17. Lane H. C., Depper J. M., Greene W. C., Whalen G., Waldmann T. A., Fauci A. S. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med. 1985 Jul 11;313(2):79–84. doi: 10.1056/NEJM198507113130204. [DOI] [PubMed] [Google Scholar]
  18. Martínez-Maza O., Crabb E., Mitsuyasu R. T., Fahey J. L., Giorgi J. V. Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J Immunol. 1987 Jun 1;138(11):3720–3724. [PubMed] [Google Scholar]
  19. Melmed R. N., Taylor J. M., Detels R., Bozorgmehri M., Fahey J. L. Serum neopterin changes in HIV-infected subjects: indicator of significant pathology, CD4 T cell changes, and the development of AIDS. J Acquir Immune Defic Syndr. 1989;2(1):70–76. [PubMed] [Google Scholar]
  20. Miedema F., Tersmette M., van Lier R. A. AIDS pathogenesis: a dynamic interaction between HIV and the immune system. Immunol Today. 1990 Aug;11(8):293–297. doi: 10.1016/0167-5699(90)90116-q. [DOI] [PubMed] [Google Scholar]
  21. Moss A. R., Bacchetti P., Osmond D., Krampf W., Chaisson R. E., Stites D., Wilber J., Allain J. P., Carlson J. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J (Clin Res Ed) 1988 Mar 12;296(6624):745–750. doi: 10.1136/bmj.296.6624.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Nishanian P., Hofmann B., Wang Y., Jackson A. L., Detels R., Fahey J. L. Serum soluble CD8 molecule is a marker of CD8 T-cell activation in HIV-1 disease. AIDS. 1991 Jul;5(7):805–812. doi: 10.1097/00002030-199107000-00003. [DOI] [PubMed] [Google Scholar]
  23. Nishanian P., Huskins K. R., Stehn S., Detels R., Fahey J. L. A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals. J Infect Dis. 1990 Jul;162(1):21–28. doi: 10.1093/infdis/162.1.21. [DOI] [PubMed] [Google Scholar]
  24. Prince H. E., Kleinman S. H., Maino V. C., Jackson A. L. In vitro activation of T lymphocytes from human immunodeficiency virus (HIV)-seropositive blood donors. I. Soluble interleukin 2 receptor (IL2R) production parallels cellular IL2R expression and DNA synthesis. J Clin Immunol. 1988 Mar;8(2):114–120. doi: 10.1007/BF00917899. [DOI] [PubMed] [Google Scholar]
  25. Prince H. E., Kleinman S., Czaplicki C., John J., Williams A. E. Interrelationships between serologic markers of immune activation and T lymphocyte subsets in HIV infection. J Acquir Immune Defic Syndr. 1990;3(5):525–530. [PubMed] [Google Scholar]
  26. Rinaldo C., Huang X. L., Piazza P., Armstrong J., Rappocciolo G., Pazin G., McMahon D., Gupta P., Fan Z., Zhang Z. Augmentation of cellular immune function during the early phase of zidovudine treatment of AIDS patients. J Infect Dis. 1991 Oct;164(4):638–645. doi: 10.1093/infdis/164.4.638. [DOI] [PubMed] [Google Scholar]
  27. el-Sadr W., Marmor M., Zolla-Pazner S., Stahl R. E., Lyden R., William D., D'Onofrio S., Weiss S. H., Saxinger W. C. Four-year prospective study of homosexual men: correlation of immunologic abnormalities, clinical status, and serology to human immunodeficiency virus. J Infect Dis. 1987 Apr;155(4):789–793. doi: 10.1093/infdis/155.4.789. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES